Cost effectiveness of autologous blood donation

Margot S. Kruskall; Arturo Pereira; Avery Comarow; David A. Lubarsky; Jeff Etchason; Steven Kleinman; Harold S. Kaplan; Cynthia Rutherford

doi:10.1056/NEJM199508173330717

Cost effectiveness of autologous blood donation

Margot S. Kruskall, Arturo Pereira, Avery Comarow, David A. Lubarsky, Jeff Etchason, Steven Kleinman, Harold S. Kaplan, Cynthia Rutherford

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Abstract

To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)¹ seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified²; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

Original language	English
Pages (from-to)	461-463
Number of pages	3
Journal	New England Journal of Medicine
Volume	333
Issue number	7
DOIs	https://doi.org/10.1056/NEJM199508173330717
State	Published - 17 Aug 1995
Externally published	Yes

Access to Document

10.1056/NEJM199508173330717

Cite this

@article{be4dbab7567b4f959f61453cbd671978,

title = "Cost effectiveness of autologous blood donation",

abstract = "To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.",

author = "Kruskall, {Margot S.} and Arturo Pereira and Avery Comarow and Lubarsky, {David A.} and Jeff Etchason and Steven Kleinman and Kaplan, {Harold S.} and Cynthia Rutherford",

year = "1995",

month = aug,

day = "17",

doi = "10.1056/NEJM199508173330717",

language = "English",

volume = "333",

pages = "461--463",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Cost effectiveness of autologous blood donation

AU - Kruskall, Margot S.

AU - Pereira, Arturo

AU - Comarow, Avery

AU - Lubarsky, David A.

AU - Etchason, Jeff

AU - Kleinman, Steven

AU - Kaplan, Harold S.

AU - Rutherford, Cynthia

PY - 1995/8/17

Y1 - 1995/8/17

N2 - To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

AB - To the Editor: The bleak conclusions that Etchason and colleagues offer about the limited usefulness and high costs of autologous blood donation (March 16 issue)1 seem premature and unwarranted. The ability to test and eliminate most donors with hepatitis B or C or the human immunodeficiency virus (HIV) is an important advance but does not ensure a completely safe blood supply. Just this year, new hepatitis viruses have been identified2; at least one is transmitted through blood transfusion (Alter HJ: personal communication). Many additional bacterial, viral, and protozoal infections are problems, and other complications of allogeneic blood transfusion are.

UR - http://www.scopus.com/inward/record.url?scp=0029148832&partnerID=8YFLogxK

U2 - 10.1056/NEJM199508173330717

DO - 10.1056/NEJM199508173330717

M3 - Letter

C2 - 7617008

AN - SCOPUS:0029148832

SN - 0028-4793

VL - 333

SP - 461

EP - 463

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Cost effectiveness of autologous blood donation

Abstract

Access to Document

Fingerprint

Cite this